The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity
Open accessAbstract
B cells play critical roles in the pathogenesis of lupus. To examine the influence of B cells on disease pathogenesis in a murine lupus model, New Zealand Black and New Zealand White F1 hybrid (NZB/W) mice were generated that were deficient for CD19 (CD19−/− NZB/W mice), a B cell-specific cell surface molecule that is essential for optimal B cell signal transduction. The emergence of anti-nuclear Abs was significantly delayed in CD19−/− NZB/W mice compared with wild type NZB/W mice. However, the pathologic manifestations of nephritis appeared significantly earlier, and survival was significantly reduced in CD19−/− NZB/W mice compared with wild type mice. These results demonstrate both disease-promoting and protective roles for B cells in lupus pathogenesis. Recent studies have identified a potent regulatory B cell subset (B10 cells) within the rare CD1dhiCD5+ B cell subset of the spleen that regulates acute inflammation and autoimmunity through the production of IL-10. In wild type NZB/W mice, the CD1dhiCD5+B220+ B cell subset that includes B10 cells was increased by 2.5-fold during the disease course, whereas CD19−/− NZB/W mice lacked this CD1dhiCD5+ regulatory B cell subset. However, the transfer of splenic CD1dhiCD5+ B cells from wild type NZB/W mice into CD19−/− NZB/W recipients significantly prolonged their survival. Furthermore, regulatory T cells were significantly decreased in CD19−/− NZB/W mice, but the transfer of wild type CD1dhiCD5+ B cells induced T regulatory cell expansion in CD19−/− NZB/W mice. These results demonstrate an important protective role for regulatory B10 cells in this systemic autoimmune disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,632
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,238
Self-citationInterleukin‐10: new perspectives on an old cytokine
Mosser, D. M., & Zhang, X. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00706.x · Cited by 1,077
Rahman, M. U. (2008) · Essentials of Physical Medicine and Rehabilitation · doi:10.1016/b978-1-4160-4007-1.50153-x · Cited by 1,019
Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S., & Bhan, A. K. (2002) · Immunity · doi:10.1016/s1074-7613(02)00274-1 · Cited by 978
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 913
Self-citationPrevention of Arthritis by Interleukin 10–producing B Cells
Mauri, C., Gray, D., Mushtaq, N., & Londei, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021293 · Cited by 860
The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.
Hayakawa, K., Hardy, R. R., Parks, D. R., & Herzenberg, L. A. (1983) · The Journal of experimental medicine · doi:10.1084/jem.157.1.202 · Cited by 812
Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice
Wolf, S. D., Dittel, B. N., Hardardottir, F., & Janeway, C. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2271 · Cited by 699
Chan, O. T. M., Hannum, L. G., Haberman, A. M., Madaio, M. P., & Shlomchik, M. J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1639 · Cited by 698
Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity
Lipsky, P. E. (2001) · Nature Immunology · doi:10.1038/ni0901-764 · Cited by 695
CD19: Lowering the Threshold for Antigen Receptor Stimulation of B Lymphocytes
Carter, R. H., & Fearon, D. T. (1992) · Science · doi:10.1126/science.1373518 · Cited by 674
Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice
Rickert, R. C., Rajewsky, K., & Roes, J. (1995) · Nature · doi:10.1038/376352a0 · Cited by 664
Manson, J. J., & Rahman, A. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-6 · Cited by 605
Mizoguchi, A., & Bhan, A. K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.705 · Cited by 582
Gordon, C., Li, C. K., & Isenberg, D. A. (2010) · Medicine · doi:10.1016/j.mpmed.2009.10.006 · Cited by 565
Engel, P., Zhou, L.-J., Ord, D. C., Sato, S., Koller, B., & Tedder, T. F. (1995) · Immunity · doi:10.1016/1074-7613(95)90157-4 · Cited by 541
Self-citationLlorente, L., Zou, W., Levy, Y., Richaud-Patin, Y., Wijdenes, J., Alcocer-Varela, J., Morel-Fourrier, B., Brouet, J. C., Alarcon-Segovia, D., Galanaud, P., et al. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.839 · Cited by 541
An Antibody-Deficiency Syndrome Due to Mutations in the CD19 Gene
van Zelm, M. C., Reisli, I., van der Burg, M., Castaño, D., van Noesel, C. J. M., van Tol, M. J. D., Woellner, C., Grimbacher, B., Patiño, P. J., van Dongen, J. J. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051568 · Cited by 540
Regulation of B Lymphocyte Responses to Foreign and Self-Antigens by the CD19/CD21 Complex
Fearon, D. T., Carroll, M. C., & Carroll, M. C. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.393 · Cited by 532
Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., & Howard, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.305 · Cited by 532
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 516
Yanaba, K., Bouaziz, J.-D., Matsushita, T., Tsubata, T., & Tedder, T. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900270 · Cited by 503
Self-citationRegulatory B cells as inhibitors of immune responses and inflammation
Bouaziz, J., Yanaba, K., & Tedder, T. F. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00661.x · Cited by 425
Self-citationCytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus
Chun, H.-Y., Chung, J.-W., Kim, H.-A., Yun, J.-M., Jeon, J.-Y., Ye, Y.-M., Kim, S.-H., Park, H.-S., & Suh, C.-H. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9104-0 · Cited by 390
B CELL IMMUNOBIOLOGY IN DISEASE: Evolving Concepts from the Clinic
Martin, F., & Chan, A. C. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090517 · Cited by 369
Suppressive Role of B Cells in Chronic Colitis of T Cell Receptor α Mutant Mice
Mizoguchi, A., Mizoguchi, E., Smith, R. N., Preffer, F. I., & Bhan, A. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1749 · Cited by 345
Chan, O., & J. Shlomchik, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.51 · Cited by 306
Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases
Ramos-Casals, M., Soto, M., Cuadrado, M., & Khamashta, M. (2009) · Lupus · doi:10.1177/0961203309106174 · Cited by 304
Not always the bad guys: B cells as regulators of autoimmune pathology
Fillatreau, S., Gray, D., & Anderton, S. M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2315 · Cited by 295
Hagiwara, E., Gourley, M. F., Lee, S., & Klinman, D. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390305 · Cited by 287
Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Gröndal, G., Gunnarsson, I., Rönnelid, J., Rogberg, S., Klareskog, L., & Lundberg, I. E. (2000) · PubMed · Cited by 287
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity
Houssiau, F., Lefebvre, C., Vanden Berghe, M., Lambert, M., Devogelaer, J.-P., & Renauld, J.-C. (1995) · Lupus · doi:10.1177/096120339500400510 · Cited by 281
The central and multiple roles of B cells in lupus pathogenesis
Chan, O. T. M., Madaio, M. R., Shlomchik, M. J., Chan, O. I. M., Madaio, M. P., & Shlomchik, M. J. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01310.x · Cited by 281
The ‘short’ history of regulatory B cells
Mauri, C., & Ehrenstein, M. R. (2008) · Trends in Immunology · doi:10.1016/j.it.2007.10.004 · Cited by 280
Sato, S., Ono, N., Steeber, D. A., Pisetsky, D. S., & Tedder, T. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4371 · Cited by 267
Self-citationYin, Z., Bahtiyar, G., Zhang, N., Liu, L., Zhu, P., Robert, M. E., McNiff, J., Madaio, M. P., & Craft, J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2148 · Cited by 227
Pathogenic Roles of B Cells in Human Autoimmunity
Martin, F., & Chan, A. C. (2004) · Immunity · doi:10.1016/s1074-7613(04)00112-8 · Cited by 224
Fujimoto, M., Fujimoto, Y., Poe, J. C., Jansen, P. J., Lowell, C. A., DeFranco, A. L., & Tedder, T. F. (2000) · Immunity · doi:10.1016/s1074-7613(00)00007-8 · Cited by 215
Self-citationInaoki, M., Sato, S., Weintraub, B. C., Goodnow, C. C., & Tedder, T. F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1923 · Cited by 193
Self-citationBuhl, A. M., Pleiman, C. M., Rickert, R. C., & Cambier, J. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1897 · Cited by 172
Protective and Pathogenic Roles for B Cells during Systemic Autoimmunity in NZB/W F1 Mice
Haas, K. M., Watanabe, R., Matsushita, T., Nakashima, H., Ishiura, N., Okochi, H., Fujimoto, M., & Tedder, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902391 · Cited by 164
Self-citationWaters, S. T., McDuffie, M., Bagavant, H., Deshmukh, U. S., Gaskin, F., Jiang, C., Tung, K. S. K., & Fu, S. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031519 · Cited by 160
Passwell, J., Schreiner, G. F., Nonaka, M., Beuscher, H. U., & Colten, H. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113780 · Cited by 160
Modulation of B Lymphocyte Antigen Receptor Signal Transduction by a CD19/CD22 Regulatory Loop
Fujimoto, M., Bradney, A. P., Poe, J. C., Steeber, D. A., & Tedder, T. F. (1999) · Immunity · doi:10.1016/s1074-7613(00)80094-1 · Cited by 135
Self-citationBuhl, A. M., & Cambier, J. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4438 · Cited by 128
CD19 Expression in B Cells Is Important for Suppression of Contact Hypersensitivity
Watanabe, R., Fujimoto, M., Ishiura, N., Kuwano, Y., Nakashima, H., Yazawa, N., Okochi, H., Sato, S., Tedder, T. F., & Tamaki, K. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061279 · Cited by 123
Self-citationFujimoto, M., Poe, J. C., Jansen, P. J., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7088 · Cited by 122
Self-citationMatsushita, T., Fujimoto, M., Hasegawa, M., Komura, K., Takehara, K., Tedder, T. F., & Sato, S. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050923 · Cited by 112
Self-citationRegulation of B cell fates by BCR signaling components
Kurosaki, T. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00344-8 · Cited by 106
B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus
Eisenberg, R. A., & Albert, D. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0042 · Cited by 101
CD19 Function in Central and Peripheral B-Cell Development
Nagro, C. J. D., Otero, D. C., Anzelon-Mills, A. N., Omori, S. A., Kolla, R. V., & Rickert, R. C. (2005) · Immunologic Research · doi:10.1385/ir:31:2:119 · Cited by 89
B cell biology and dysfunction in SLE.
Anolik, J. H. (2007) · PubMed · Cited by 75
CD5+ B cells in autoimmune disease and lymphoid malignancy
Shirai, T., Hirose, S., Okada, T., et al. (1991) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(91)90016-4 · Cited by 66
Atencio, S., Amano, H., Izui, S., & Kotzin, B. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4159 · Cited by 61
A perspective on B-cell-targeting therapy for SLE
Looney, R. J., Anolik, J. H., & Sanz, I. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0213-x · Cited by 60
B Cell Depletion with Anti-CD79 mAbs Ameliorates Autoimmune Disease in MRL/ lpr Mice
Li, Y., Chen, F., Putt, M., Koo, Y., Madaio, M. P., Cambier, J. C., Cohen, P. L., & Eisenberg, R. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2961 · Cited by 57
Tedder, T. F., Poe, J. C., Fujimoto, M., Haas, K. M., & Sato, S. (2004) · KARGER eBooks · doi:10.1159/000082087 · Cited by 57
Self-citationFujimoto, M., & Sato, S. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2006.12.004 · Cited by 50
Self-citationComplementary Roles for CD19 and Bruton’s Tyrosine Kinase in B Lymphocyte Signal Transduction
Fujimoto, M., Poe, J. C., Satterthwaite, A. B., Wahl, M. I., Witte, O. N., & Tedder, T. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5465 · Cited by 47
Self-citationTedder, T. F. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0118 · Cited by 46
Self-citationSignaling by the CD19/CD21 Complex on B Cells
Carter, R. H., & Barrington, R. A. (2003) · KARGER eBooks · doi:10.1159/000075685 · Cited by 41
B-cell targeting: a novel approach to immune intervention today and tomorrow
Dörner, T., & Lipsky, P. E. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.9.1287 · Cited by 38
Abe, J., Ueha, S., Suzuki, J., Tokano, Y., Matsushima, K., & Ishikawa, S. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080314 · Cited by 31
González‐Amaro, R., Portales‐Pérez, D. P., Baranda, L., Abud‐Mendoza, C., Llorente, L., Richaud‐Patín, Y., Alcocer-Varela, J. C., & Alarcón-Segovia, D. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1998.0228 · Cited by 15
Cited by
Immune Regulatory Function of B Cells
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,249
Iwata, Y., Matsushita, T., Horikawa, M., DiLillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M., Bernstein, S. H., Magro, C. M., Williams, A. D., et al. (2011) · Blood · doi:10.1182/blood-2010-07-294249 · Cited by 1,104
Self-citationGuidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
Matsumoto, M., Baba, A., Yokota, T., Nishikawa, H., Ohkawa, Y., Kayama, H., Kallies, A., Nutt, S. L., Sakaguchi, S., Takeda, K., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.016 · Cited by 556
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Metadata
- Authors
- Watanabe, R., Ishiura, N., Nakashima, H., Kuwano, Y., Okochi, H., Tamaki, K., Sato, S., Tedder, T. F., & Fujimoto, M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-01
- Volume
- 184
- Issue
- 9
- Pages
- 4801-4809
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2133063407
- Cited by
- 308
- References
- 68
- FWCI
- 16.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.